Literature DB >> 25756024

Association of mitochondrial deoxyribonucleic acid mutation with polymorphism in CYP2E1 gene in oral carcinogenesis.

Rahul Pandey1, Divya Mehrotra2, Carlo Catapano3, Vimal Choubey4, Rajiv Sarin5, Abbas Ali Mahdi6, Stuti Singh7.   

Abstract

BACKGROUND: Oral carcinogenesis is a complex process affected by genetic as well as environmental factors. CYP2E1 gene is involved in metabolism of number of compounds and carcinogens. Its normal functioning is required for homeostasis of free radical. Mitochondrial deoxyribonucleic acid (mtDNA) is 10-100 times more susceptible to damage than nuclear DNA. Mitochondrial DNA large scale deletions are well documented in oral cancer. However, the relationship between CYP2E1 gene polymorphisms and mtDNA damage is still not documented in literature.
MATERIALS AND METHODS: Case-control study involving 50 subjects was carried out. Deoxyribonucleic acid extraction was done from study subject tissue samples. Restriction fragment length polymorphism (RFLP) and polymerase chain reaction (PCR) amplification was done to confirm CYP2E1 gene polymorphisms. The PCR amplification was done for mtDNA 4977 bp deletion. Statistical analysis was carried out using SPSS version 11.5 with χ(2) tests.
RESULTS: c1c1 and DD polymorphisms are prevalent in North Indian population having oral cancer. These polymorphisms are significantly associated with mtDNA 4977 bp deletion.
CONCLUSION: Mitochondrial DNA damage induced by wild CYP2E1 forms and imperfect DNA repair in mtDNA may act synergistically to greatly enhance oral cancer risk.

Entities:  

Keywords:  CYP2E1; DNA; mitochondria; oral cancer

Year:  2012        PMID: 25756024      PMCID: PMC3941659          DOI: 10.1016/S2212-4268(12)60003-7

Source DB:  PubMed          Journal:  J Oral Biol Craniofac Res        ISSN: 2212-4268


  22 in total

1.  Elucidation of CYP2E1 5' regulatory RsaI/Pstl allelic variants and their role in risk for oral cancer.

Authors:  S Liu; J Y Park; S P Schantz; J C Stern; P Lazarus
Journal:  Oral Oncol       Date:  2001-07       Impact factor: 5.337

2.  Comprehensive scanning of the entire mitochondrial genome for mutations.

Authors:  Lee-Jun C Wong; Min-Hui Liang; Haeyoung Kwon; John Park; Ren-Kui Bai; Duan-Jun Tan
Journal:  Clin Chem       Date:  2002-11       Impact factor: 8.327

3.  CYP2E1 polymorphisms and gene-environment interactions in the risk of upper aerodigestive tract cancers among Indians.

Authors:  S S Soya; T Vinod; K S Reddy; S Gopalakrishnan; C Adithan
Journal:  Pharmacogenomics       Date:  2008-05       Impact factor: 2.533

4.  Facile detection of mitochondrial DNA mutations in tumors and bodily fluids.

Authors:  M S Fliss; H Usadel; O L Caballero; L Wu; M R Buta; S M Eleff; J Jen; D Sidransky
Journal:  Science       Date:  2000-03-17       Impact factor: 47.728

5.  Head and neck cancer cell lines exhibit differential mitochondrial repair deficiency in response to 4NQO.

Authors:  Michael M Kim; Chad A Glazer; Elizabeth Mambo; Aditi Chatterjee; Ming Zhao; David Sidransky; Joseph A Califano
Journal:  Oral Oncol       Date:  2005-11-02       Impact factor: 5.337

6.  Genetic polymorphisms of ADH2, ADH3, CYP4502E1 Dra-I and Pst-I, and ALDH2 in Spanish men: lack of association with alcoholism and alcoholic liver disease.

Authors:  Francesc Vidal; Alfons Lorenzo; Teresa Auguet; Montserrat Olona; Montserrat Broch; Cristina Gutiérrez; Carmen Aguilar; Pere Estupiñà; Mauro Santos; Cristóbal Richart
Journal:  J Hepatol       Date:  2004-11       Impact factor: 25.083

7.  Genetic polymorphisms of CYP2E1, GSTM1, and GSTT1; environmental factors and risk of oral cancer.

Authors:  H C Hung; J Chuang; Y C Chien; H D Chern; C P Chiang; Y S Kuo; A Hildesheim; C J Chen
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  1997-11       Impact factor: 4.254

Review 8.  Mechanistic considerations in the molecular epidemiology of head and neck cancer.

Authors:  Paul Brennan; Paolo Boffetta
Journal:  IARC Sci Publ       Date:  2004

9.  Restriction fragment length polymorphism of the human CYP2E1 (cytochrome P450IIE1) gene and susceptibility to lung cancer: possible relevance to low smoking exposure.

Authors:  F Uematsu; S Ikawa; H Kikuchi; I Sagami; R Kanamaru; T Abe; K Satoh; M Motomiya; M Watanabe
Journal:  Pharmacogenetics       Date:  1994-04

10.  Association between restriction fragment length polymorphism of the human cytochrome P450IIE1 gene and susceptibility to lung cancer.

Authors:  F Uematsu; H Kikuchi; M Motomiya; T Abe; I Sagami; T Ohmachi; A Wakui; R Kanamaru; M Watanabe
Journal:  Jpn J Cancer Res       Date:  1991-03
View more
  5 in total

Review 1.  Does CYP2E1 RsaI/PstI polymorphism confer head and neck carcinoma susceptibility?: A meta-analysis based on 43 studies.

Authors:  Xianlu Zhuo; Jue Song; Jian Liao; Wei Zhou; Huiping Ye; Qi Li; Zhaolan Xiang; Xueyuan Zhang
Journal:  Medicine (Baltimore)       Date:  2016-10       Impact factor: 1.889

2.  Correlation of Sperm Mitochondrial DNA 7345 bp and 7599 bp Deletions with Asthenozoospermia in Jordanian Population.

Authors:  Mazhar Salim Al Zoubi; Ali M Al-Talafha; Emad Al Sharu; Bahaa Al-Trad; Ayman Alzu'bi; Manal Issam AbuAlarjah; Qasem Shehab; Mohammad Alsmadi; Khalid M Al-Batayneh
Journal:  J Reprod Infertil       Date:  2021 Jul-Sep

3.  Mitochondrial common deletion, a potential biomarker for cancer occurrence, is selected against in cancer background: a meta-analysis of 38 studies.

Authors:  Hezhongrong Nie; Hongying Shu; Rasika Vartak; Amanda Claire Milstein; Yalin Mo; Xiaoqin Hu; Hezhi Fang; Lijun Shen; Zhinan Ding; Jianxin Lu; Yidong Bai
Journal:  PLoS One       Date:  2013-07-04       Impact factor: 3.240

4.  Analysis of the role of rs2031920 and rs3813867 polymorphisms within the cytochrome P450 2E1 gene in the risk of squamous cell carcinoma.

Authors:  Hai Zhang; Haiyan Li; Huanxin Yu
Journal:  Cancer Cell Int       Date:  2018-05-01       Impact factor: 5.722

Review 5.  The Uprising of Mitochondrial DNA Biomarker in Cancer.

Authors:  Siti Zulaikha Nashwa Mohd Khair; Siti Muslihah Abd Radzak; Abdul Aziz Mohamed Yusoff
Journal:  Dis Markers       Date:  2021-07-15       Impact factor: 3.434

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.